Lidak Pharmaceuticals announced Tuesday that its class Acommon stock, class B warrants and class C warrants will begintrading on the NASDAQ National Market System as of Sept. 30.These securities will continue to trade under the symbolsLDAKA, LDAKM and LDAKZ, respectively. The La Jolla, Calif.,company's stock had been trading on the NASDAQ small-capmarket, explained Michael Lorber, Lidak's vice president andchief financial officer.

(c) 1997 American Health Consultants. All rights reserved.